Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.6.5 instead of v3.6.4, indicating a small site update to the ClinicalTrials.gov interface for the record history page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.6.4 has been added to the study's revision history and the older v3.6.3 entry has been removed, reflecting an update to the record's version history on the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new history entry on 2026-07-06 updates the Study Status to Completed and notes that no participants are being recruited; the 2026-02-25 entry was removed from the history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's footer revision label was updated to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision entry v3.6.2 appears in the record history, and the older v3.6.0 entry is removed. This documents a backend/platform update rather than changes to study data or on-page text.SummaryDifference0.0%

- Check60 days agoChange DetectedThe latest record version indicates recruitment has ended, and the revision metadata shows a new version (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.